Brian D. Kavanagh

1992–2024 年に発表

75
論文数
19,249
被引用数
61
h 指数
73
i10 指数

被引用数

Brian D. Kavanagh の年別被引用数1995 年: 被引用 2 件1996 年: 被引用 3 件1997 年: 被引用 3 件1998 年: 被引用 3 件1999 年: 被引用 14 件2000 年: 被引用 8 件2001 年: 被引用 17 件2002 年: 被引用 11 件2003 年: 被引用 20 件2004 年: 被引用 18 件2005 年: 被引用 22 件2006 年: 被引用 30 件2007 年: 被引用 35 件2008 年: 被引用 53 件2009 年: 被引用 84 件2010 年: 被引用 112 件2011 年: 被引用 126 件2012 年: 被引用 123 件2013 年: 被引用 112 件2014 年: 被引用 137 件2015 年: 被引用 125 件2016 年: 被引用 129 件2017 年: 被引用 134 件2018 年: 被引用 172 件2019 年: 被引用 625 件2020 年: 被引用 723 件2021 年: 被引用 617 件2022 年: 被引用 408 件2023 年: 被引用 226 件2024 年: 被引用 456 件2025 年: 被引用 156 件2026 年: 被引用 3 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,683 件、この内訳の 29.7%中国: 引用元論文 438 件、この内訳の 7.7%イタリア: 引用元論文 359 件、この内訳の 6.3%カナダ: 引用元論文 308 件、この内訳の 5.4%オランダ: 引用元論文 287 件、この内訳の 5.1%ドイツ: 引用元論文 284 件、この内訳の 5%イギリス: 引用元論文 265 件、この内訳の 4.7%スイス: 引用元論文 206 件、この内訳の 3.6%フランス: 引用元論文 196 件、この内訳の 3.4%日本: 引用元論文 168 件、この内訳の 3%オーストラリア: 引用元論文 148 件、この内訳の 2.6%スペイン: 引用元論文 135 件、この内訳の 2.4%
0%29.7%その他 21.1%

分野

  • Medicine77%
  • Physics and Astronomy12.6%
  • Biochemistry, Genetics and Molecular Biology5.3%
  • Immunology and Microbiology2.7%
  • Engineering0.6%
  • Agricultural and Biological Sciences0.3%
  • その他1.5%

トピック

  • Advanced Radiotherapy Techniques9.3%
  • Lung Cancer Diagnosis and Treatment6.9%
  • Lung Cancer Treatments and Mutations5.9%
  • Hepatocellular Carcinoma Treatment and Prognosis5.7%
  • Brain Metastases and Treatment4.5%
  • Lung Cancer Research Studies4.4%
  • その他63.3%

共著者

全論文

検索で開く
  1. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 1,270

  2. Stereotactic body radiation therapy: The report of AAPM Task Group 101

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Medical Physics 2010 被引用: 2,175

  3. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 1,086

  4. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , - Journal of Thoracic Oncology 2012 被引用: 677

  5. Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 461

  6. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy

    著者: , , , , - International Journal of Radiation Oncology*Biology*Physics 2019 被引用: 168

  7. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth Bernstein, Joshua S. Silverman, Inga S. Grills, Z.A. Siddiqui, Justin C. Yuan, Jason P. Sheehan, Diogo Cordeiro, Kename Nosaki, T. Seto, Christopher P. Deibert, Vivek Verma, Samuel E. Day, Lia M. Halasz, Ronald E. Warnick, Daniel M. Trifiletti, Joshua D. Palmer, Albert Attia, Benjamin Li, Christopher P. Cifarelli, Paul D. Brown, John A. Vargo, Stephanie E. Combs, Kerstin A. Kessel, Stefan Rieken, Samir Patel, Matthias Gückenberger, Nicolaus Andratschke, Brian D. Kavanagh, Tyler P. Robin - JAMA Oncology 2020 被引用: 215

  8. Radiation-Associated Liver Injury

    著者: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2010 被引用: 778

  9. High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview

    著者: , , , , , - International Journal of Radiation Oncology*Biology*Physics 2021 被引用: 141

  10. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy

    著者: , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2010 被引用: 666

  11. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 331

  12. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion

    著者: , , , , , , , , - Blood 2008 被引用: 253

  13. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

    著者: , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 1,095

  14. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 804

  15. Stereotactic Body Radiation Therapy in Multiple Organ Sites

    著者: , , , , - Journal of Clinical Oncology 2007 被引用: 443

  16. Radiation-Associated Kidney Injury

    著者: , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2010 被引用: 312

  17. Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 72

  18. Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 285

  19. Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non–Small Cell Lung Cancer

    著者: , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2018 被引用: 145

  20. Radiation Dose–Volume Effects in the Stomach and Small Bowel

    著者: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2010 被引用: 548

  21. Stereotactic body radiotherapy for colorectal liver metastases

    著者: , , , , , , , , , , - Cancer 2011 被引用: 299

  22. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sue S. Yom, David A. Palma - International Journal of Radiation Oncology*Biology*Physics 2020 被引用: 227

  23. Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy

    著者: , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2021 被引用: 66

  24. Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary

    著者: , , , , , , , , - Practical Radiation Oncology 2011 被引用: 209